MedTrace Logo

Online Suicide Prevention and Intervention Training for Secondary School Counselors

NCT07432438 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-25

No results posted yet for this study

Summary

The aim of this study is to develop and evaluate the effectiveness of the Online Suicide Prevention and Intervention Training Program (Çevrimiçi İntihar Önleme ve Müdahale Eğitim Programı - ÇİÖMEP) for school counselors working in secondary education. Suicide is a major public health concern among adolescents, and school counselors play a vital role in early identification and intervention. This research uses a randomized controlled trial (RCT) design to determine if the training improves counselors' knowledge, perceived competence, and attitudes toward suicide prevention while reducing the stigma associated with suicidal behavior.

Conditions

Interventions

BEHAVIORAL

Online Suicide Prevention and Intervention Training Program (ÇİÖMEP)

This is an online training program designed for school counselors. It consists of 4 sessions held over 2 days. The training covers: 1. Awareness: Understanding suicide myths, warning signs, and attitudes. 2. Assessment: How to assess suicide risk in students and create safety plans. 3. Intervention: Specific counseling techniques to help students who are at risk (e.g., instilling hope, problem-solving). 4. Crisis Management: How to manage a crisis in school and what to do after a suicide occurs (postvention)

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER

  • Aydin Adnan Menderes University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-04-30
Completion
2026-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07432438 on ClinicalTrials.gov